Centre's lens on unapproved antibiotic combos, asks states to monitor availability

Centre requests states for licensed antibiotics. Study finds banned drugs still sold, with sales rising. Pharma firms promote new components to bypass rules, impacting resistance. CDSCO banned 26 antibiotic combinations in 2018, but many remain. Some FDCs lack CDSCO approval, raising concerns about state-level decisions lacking expertise.
|
||||
|
||||
You Might Like💡 newsR Knowledge: Other News Mentions
|